Stock-Based Compensation

3 Months Ended

May 04, 2019

7.	Stock-Based Compensation

The compensation costs that have been charged against income for the 13 weeks ended May 4, 2019 and May 5, 2018 were as follows (in thousands):

	13 Weeks Ended
	May 4, 2019		May 5, 2018
Stock-based compensation expense by type:
Stock options	$	92	$	160
Restricted stock units		363		1,524
Employee stock purchases		29		29
Director deferred compensation		23		23
Total stock-based compensation expense		507		1,736
Income tax benefit recognized		113		393
Stock-based compensation expense, net of income tax	$	394	$	1,343

Expense for restricted stock units is shown net of forfeitures of $1.3 million and $6,000 for the 13 weeks ended May 4, 2019 and May 5, 2018, respectively.

In the 13 weeks ended May 4, 2019 and May 5, 2018, we granted the following equity awards:

	13 Weeks Ended
	May 4, 2019		May 5, 2018
Stock options		16,798		19,994
Restricted stock unit awards		191,021		169,572
Performance-based restricted stock unit awards		34,300		44,700
Deferred stock units		1,027		979

At May 4, 2019, the total compensation costs related to nonvested restricted stock unit awards not yet recognized was $7.3 million and the weighted-average period over which such awards are expected to be recognized was 2.9 years. There were no compensation costs related to nonvested stock options at May 4, 2019.

Under the 2012 Non-Employee Director Equity Plan (2012 Plan), a total of 13,858 and 4,435 shares of our common stock were awarded during the 13 weeks ended May 4, 2019 and May 5, 2018, respectively, as part of the annual equity award to directors in the first quarter.

The weighted-average grant date fair value of stock options granted during the 13 weeks ended May 4, 2019 and May 5, 2018 was $5.46 and $7.15 per share, respectively.

The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:

	13 Weeks Ended
	May 4, 2019		May 5, 2018
Shares purchased		9,925		6,554
Average price per share	$	12.16	$	17.34
Weighted average fair value at grant date	$	3.14	$	4.53